Cambridge Investment Research Advisors’s Direxion HCM Tactical Enhanced US ETF HCMT Stock Holding History

Cambridge Investment Research Advisors’s Portfolio HCMT Stock Details HCMT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$873K	Sell	24,804 -70,037	-74%	-$2.65M	﹤0.01%	2291
2025 Q4	$3.66M	Sell	94,841 -730	-0.8%	-$28.1K	0.01%	1100
2025 Q3	$3.58M	Sell	95,571 -136,366	-59%	-$4.72M	0.01%	1102
2025 Q2	$7.56M	Sell	231,937 -3,050	-1%	-$87K	0.02%	662
2025 Q1	$7.1M	Buy	234,987 +5,999	+3%	+$213K	0.02%	637
2024 Q4	$8.26M	Buy	228,988 +8,679	+4%	+$320K	0.03%	568
2024 Q3	$7.77M	Buy	220,309 +204,700	+1,311%	+$6.84M	0.03%	596
2024 Q2	$531K	Buy	15,609 +3,418	+28%	+$106K	﹤0.01%	2252
2024 Q1	$377K	Sell	12,191 -70	-0.6%	-$2.02K	﹤0.01%	2524
2023 Q4	$326K	Buy	+12,261	New	+$301K	﹤0.01%	2536

Other funds holding HCMT

HCM

Howard Capital Management Roswell, Georgia $6.11B AUM 33.56% 1-Year Est. Return

BCI

Brinker Capital Investments Berwyn, Pennsylvania $11.7B AUM 21.33% 1-Year Est. Return

DWS

Discipline Wealth Solutions Greenville, South Carolina $950M AUM 16.22% 1-Year Est. Return

WWA

Wealth Watch Advisors Englewood, Colorado $239M AUM 21.17% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

NewEdge Advisors New Orleans, Louisiana $27.7B AUM 22.98% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return

FIA

Foundations Investment Advisors Phoenix, Arizona $8.07B AUM 24.97% 1-Year Est. Return

WCM

WealthTrak Capital Management Virginia Beach, Virginia $140M AUM 17% 1-Year Est. Return

AWA

Arete Wealth Advisors Chicago, Illinois $1.33B AUM 25.12% 1-Year Est. Return

Cambridge Investment Research Advisors's HCMT Position: Q1 2026 in Review

Cambridge Investment Research Advisors reduced its Direxion HCM Tactical Enhanced US ETF (HCMT) stake by 74% in Q1 2026, selling an estimated $2.65M and leaving 24,804 shares worth $873K. The position accounts for ﹤0.01% of the portfolio, ranked #2291.

Cambridge Investment Research Advisors first reported a position in HCMT in Q4 2023 and has held it in 10 quarters since. The position peaked at $8.26M in Q4 2024. 36 funds tracked by Wall St. Rank hold HCMT as of Q1 2026.

Cambridge Investment Research Advisors held 24,804 shares of Direxion HCM Tactical Enhanced US ETF worth $873K as of Q1 2026.
Cambridge Investment Research Advisors sold 70,037 Direxion HCM Tactical Enhanced US ETF shares in Q1 2026, an estimated $2.65M.
Direxion HCM Tactical Enhanced US ETF made up ﹤0.01% of Cambridge Investment Research Advisors's portfolio in Q1 2026, its #2291 holding.
Cambridge Investment Research Advisors first reported a position in Direxion HCM Tactical Enhanced US ETF in Q4 2023 and has held it in 10 quarters since.
Cambridge Investment Research Advisors's Direxion HCM Tactical Enhanced US ETF position peaked at $8.26M in Q4 2024.
36 funds tracked by Wall St. Rank held Direxion HCM Tactical Enhanced US ETF as of Q1 2026.

Based on Cambridge Investment Research Advisors's 13F filing for Q1 2026, filed 30 Apr 2026.